Why Novo Nordisk Stock Popped Today
Viking Therapeutics (NASDAQ: VKTX) stock collapsed in morning trading Tuesday, down more than 40% after reporting mixed results for its GLP-1 weight loss pill VK2735. As Viking shares plummet, however, one rival is having a better day.
Novo Nordisk (NYSE: NVO) stock is up 2.2% through 10:30 a.m. ET on Viking's bad news.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€22.20
0.450%
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Viking Therapeutics Inc.
Based on the current price of 22.2 € the target price of 45 € shows a potential of 102.75% for Viking Therapeutics Inc which would more than double the current price.
